These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38728300)

  • 1. Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
    Kumar A; Misra G; Mohandas S; Yadav PD
    PLoS One; 2024; 19(5):e0300507. PubMed ID: 38728300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus.
    Ali MT; Morshed MM; Hassan F
    Interdiscip Sci; 2015 Jun; 7(2):177-85. PubMed ID: 26156209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
    Srivastava S; Verma S; Kamthania M; Saxena AK; Pandey KC; Pande V; Kolbe M
    PLoS One; 2023; 18(3):e0282580. PubMed ID: 36920996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah
    Mohammed AA; Shantier SW; Mustafa MI; Osman HK; Elmansi HE; Osman IA; Mohammed RA; Abdelrhman FA; Elnnewery ME; Yousif EM; Mustafa MM; Elfadol NM; Abdalla AI; Mahmoud E; Yagaub AA; Ahmed YA; Hassan MA
    J Immunol Res; 2020; 2020():2567957. PubMed ID: 32377531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
    Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
    Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors.
    Kalbhor MS; Bhowmick S; Alanazi AM; Patil PC; Islam MA
    Biophys Chem; 2021 Mar; 270():106537. PubMed ID: 33450550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus.
    Soltan MA; Eldeen MA; Elbassiouny N; Mohamed I; El-Damasy DA; Fayad E; Abu Ali OA; Raafat N; Eid RA; Al-Karmalawy AA
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus.
    Albutti A
    Saudi Pharm J; 2023 Dec; 31(12):101826. PubMed ID: 38028215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
    Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
    Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus.
    Rahman MM; Puspo JA; Adib AA; Hossain ME; Alam MM; Sultana S; Islam A; Klena JD; Montgomery JM; Satter SM; Shirin T; Rahman MZ
    Int J Pept Res Ther; 2022; 28(4):123. PubMed ID: 35761851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
    Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
    J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates.
    Isaacs A; Cheung STM; Thakur N; Jaberolansar N; Young A; Modhiran N; Bailey D; Graham SP; Young PR; Chappell KJ; Watterson D
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
    van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell Epitope-based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach.
    Krishnamoorthy PKP; Subasree S; Arthi U; Mobashir M; Gowda C; Revanasiddappa PD
    Comb Chem High Throughput Screen; 2020; 23(8):788-796. PubMed ID: 32338213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.